0

CHEST Podcasts

Each month, CHEST hosts a discussion with the authors of articles from the current issue, adding context and commentary to the challenges facing clinicians in the fields of pulmonary, critical care, and sleep medicine. As Podcast Editor and Moderator, D. Kyle Hogarth, MD, FCCP explains: "The goal of each conversation is to pique our listeners' interest and compel them to read additional work by the featured authors or on the topics covered."

To listen, click on a podcast player below. Notice that hovering over the player or clicking on it activates additional helpful controls, such as download, share via email, and mute.

Subscribe to the podcast via iTunes > 


December 2014: Effectiveness of Robotic-Assisted vs Thoracoscopic Lobectomy

Duration: 36 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants:Subroto Paul, MD, FCCP; Malcolm M. DeCamp, MD, FCCP

,

Article Discussed:

  • Paul S, Jalbert J, Isaacs AJ, Altorki NK, Isom OW, Sedrakyan A. Comparative Effectiveness of Robotic-Assisted vs Thoracoscopic Lobectomy. CHEST. 2014;146(6):1505-1512. Full Text
  • McCarthy DP, DeCamp MM. Robotic Lobectomy and the Principles of Technology Diffusion. CHEST. 2014;146(6):1425-1426. Full Text

Special Topic:  High Quality Lung Cancer Screening: CHEST/ATS Policy Statement

Duration: 28 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Peter J. Mazzone, MD, FCCP; Gerard A. Silvestri, MD, FCCP

,

Article Discussed:

  • Mazzone, PJ, Powell CA, Arenberg, D et al. Components Necessary for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement. CHEST. 2014 doi:10.1378/chest.14-2500. Full Text

November 2014: Long-term Outcomes For Patients Who Develop New-Onset Atrial Fibrillation During Sepsis 

Duration: 36 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Allan J. Walkey, MD; Gregory Y. H. Lip, MD

,

Articles Discussed:

  • Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long-term Outcomes Following Development of New-Onsent Atrial Fibrillation During Sepsis. CHEST. 2014:146(5)1187-1195. Full Text
  • Lau YC, Lip GYH. Atrial Fibrillation During Sepsis: A Determination of Long-term Outcomes? CHEST. 2014:146(5)1183-1140. Full Text

October 2014: Management of Cough: Overview of CHEST Guideline and Expert Panel Report 

Duration: 36 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Richard S. Irwin, MD, Master FCCP; Tamara Pringsheim, MD

,

Article Discussed:

  • Overview of the Management of Cough: CHEST Guideline and Expert Panel Report. CHEST. 2014:146(4)885-889. Full Text

September 2014: Care of the Critically Ill and Injured During Pandemics and Disasters: Newly Updated CHEST Consensus Statement 

Duration: 43 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants:Michael D. Christian, MD, FRCPC, FCCP; Niranjan Kissoon, MBBS, FRCPC; Christian E. Sandrock, MD, MPH, FCCP

,

Articles Discussed:

  • Christian MD, Devereaux AV, Dichter JR, et al. Introduction and Executive Summary: Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement. CHEST. 2014:146(4_suppl):8S-34S. Full Text
  • Sandrock CE. Care of the Critically Ill and Injured During Pandemics and Disasters. CHEST. 2014;146(4):881-883. Full Text

August 2014: Pulmonary Arterial Hypertension: New CHEST Guidelines and New CDC Report 

Duration: 28 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Terence K. Trow, MD, FCCP; Mary G. George, MD; Anna R. Hemnes, MD

,

Articles Discussed:

  • Taichman DB, Ornelas J, Chung L, et al. Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults. CHEST. 2014;146(2):449-475. Full Text
  • George MG, Schieb LJ, Ayala C, Talwalkar A, Levant S. Pulmonary Hypertension Surveillance: United States, 2001 to 2010. CHEST. 2014;146(2):476-495. Full Text
  • Hemnes AR. Pulmonary Arterial Hypertension Treatment Guidelines: New Answers and Even more Questions. CHEST. 2014;146(2):239-241. Full Text

July 2014: Interstitial Lung Abnormalities in Rheumatoid Arthritis 

Duration: 46 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Tracy J. Doyle, MD, MPH; Ivan O. Rosas, MD, FCCP; Gregory P. Cosgrove, MD, FCCP

,

Articles Discussed:

  • Doyle TJ, Dellaripa PF, Batra K, et al. Functional Impact of a Spectrum of Interstitial Lung Abnormalities in Rheumatoid Arthritis. CHEST. 2014;146(1):41-50. Full Text
  • Fischer A, Cosgrove GP. Interstitial Lung Abnormalities in Rheumatoid Arthritis Are Common and Important. CHEST. 2014;146(1):8-10. Full Text

July 2014: Giants in Chest Medicine: Lawrence D. H. Wood, MD, PhD 

Duration: 60 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Lawrence D. H. Wood, MD, PhD

,

Article Discussed:

  • Hall JB. Giants in Chest Medicine: Lawrence D. H. Wood, MD, PhD. CHEST. 2014;146(1):13-15. Full Text

June 2014: Modifying Criteria for Systemic Inflammatory Response Syndrome After Cardiac Surgery To Improve Its Predictive Value 

Duration: 33 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Simon J. Finney, PhD, MBChB; Arthur P. Wheeler, MD, FCCP

,

Articles Discussed:

  • MacCallum NS, Finney SJ, Gordon SE, Quinlan GJ, Evans TW. Modified Criteria for the Systemic InflammatoryResponse Syndrome Improves Their Utility Following Cardiac Surgery. CHEST. 2014;145(6):1197-1203. Full Text
  • Semler MW, Wheeler AP. Systemic Inflammatory Response Syndrome After Cardiac Surgery: Time for a Change. CHEST. 2014;145(6):1181-1182. Full Text

May 2014: Special Topic: Reaction to the CMS Advisory Group Recommendation Not to Reimburse for Low-Dose CT Screening for Lung Cancer 

Duration: 46 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Frank C. Detterbeck, MD, FCCP; Scott Manaker, MD, PhD, FCCP; David F. Yankelovitz, MD

,

Topic Discussed:

  • Recent vote of the Centers for Medicare and Medicaid Services (CMS) national coverage determination panel that there is not enough evidence to warrant Medicare coverage of low-dose CT screening for lung cancer. Final decision to be made in 2015.

April 2014: Can ILD-GAP Model Predict Mortality in Chronic ILD Subtypes? 

Duration: 31 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Christopher J. Ryerson, MD; Athol Wells, MD

,

Articles Discussed:

  • Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting Survival Across Interstitial Lung Disease: The ILD-GAP Model. CHEST. 2014;145(4):723-728. Full Text
  • Wells AU, Antoniou KM. The Prognostic Value of the GAP Model In Chronic Interstitial Lung Disease: The Quest for a Staging System. CHEST. 2014;145(4):672-674. Full Text

April 2014: Risk of Cross Infection Great Enough To Warrant Exclusion of Adults at Cystic Fibrosis Events?

Duration: 50 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Manu Jain, MD; Steven L. Shepherd, MPH

,

Articles Discussed:

  • Jain M, Saiman LM, Sabadosa K, LiPuma JJ. Point: Does the Risk of Cross Infection Warrant the Exclusion of Adults With Cystic Fibrosis From Cystic Fibrosis Foundation Results? Yes. CHEST. 2014;145(4):678-680. Full Text
  • Shepherd SL, Goodrich EJ, Desch J, Quinton PM. Counterpoint: Does the Risk of Cross Infection Warrant the Exclusion of Adults With Cystic Fibrosis From Cystic Fibrosis Foundation Results? CHEST. 2014;145(4):680-683. Full Text
  • Jain M, Saiman LM, Sabadosa K, LiPuma JJ. Rebuttal From Dr Jain et al. CHEST. 2014;145(4):683-684. Full Text
  • Shepherd SL, Goodrich EJ, Desch J, Quinton PM. Rebuttal From Mr Shepherd et al. CHEST. 2014;145(4):684-685. Full Text

March 2014: Radiation Risk From Lung Cancer Screening: How Does It Compare to Other Radiation Risks?

Duration: 35 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Robert J. McCunney, MD, MPH; David C. Christiani, MD, MPH, FCCP

,

Articles Discussed:

  • McCunney RJ, Li J. Radiation Risks in Lung Cancer Screening Programs: A Comparison With Nuclear Industry Workers and Atomic Bomb Surviviors. CHEST. 2014;145(3):618-624. Full Text
  • Christiani DC. Radiation Risks From Lung Cancer Screening: Glowing in the Dark? CHEST. 2014;145(3):439-440. Full Text

February 2014: Genetic Mutations for Pulmonary Capillary Hemangiomatosis Discovered

Duration: 37:23 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: C. Gregory Elliott, MD, FCCP; David Langlaben, MD

,

Articles Discussed:

  • Best EH, Sumner KL, Austin ED et al. EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis. CHEST. 2014;145(2):226-230. Full Text
  • Langlaben D. Pulmonary Capillary Hemangiomatosis: The Puzzle Takes Shape. CHEST. 2014;145(2):197-198. Full Text

February 2014: Implications of the Sunshine Act for Research Physicians 

Duration: 35 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Richard S. Saver, JD

,

Article Discussed:

  • Saver RS. Shadows Amid the Sunshine: Regulating Financial Conflicts in Medical Research. CHEST. 2014;145(2):379-386. Full Text

January 2014: Lack of Association of Vitamin D With Exacerbations in Patients With COPD

Duration: 22 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Milo A. Puhan, MD, PhD; David M. Mannino, MD, FCCP

,

Articles Discussed:

  • Puhan MA, Siebeling L, Frei A, Zoller M Bischoff-Ferrari H, ter Riet G. No Association of 25-Hydroxyvitamin D With Exacerbations in Primary Care Patients With COPD. CHEST. 2014;145(1):37-43. Full Text
  • Mannino DM. Is Vitamin D's "Moment in the Sun" Behind Us? CHEST. 2014;145(1):5-6. Full Text

January 2014: Routine Fibrinolytics Administered Intrapleurally for Complicated Parapneumonic Effussion? 

Duration: 36:35 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Najib M. Rahman, DPhil; Gene Colice, MD, FCCP

,

Articles Discussed:

  • Corcoran JP, Rahman NM. Point: Should Fibrinolytics Be Routinely Administered Intrapleurally for Management of a Complicated Parapneumonic Effusion? Yes. CHEST. 2014;145(1):14-17. Full Text
  • Colice G, Idell S. Counterpoint: Should Fibrinolytics Be Routinely Administered Intrapleurally for Management of a Complicated Parapneumonic Effusion? No. CHEST. 2014;145(1):17-20. Full Text
  • Corcoran JP, Rahman NM. Rebuttal From Drs Corcoran and Rahman. CHEST. 2014;145(1):20-21. Full Text
  • Colice G, Idell S. Rebuttal From Drs Colice and Idell. CHEST. 2014;145(1):21-23. Full Text 

December 2013: α1-Antitrypsin Deficiency: 50 Years On

Duration: 38:11 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Robert A. Stockley, MD; Kenneth R. Chapman, MD

,

Article Discussed:

  • Stockley RA. a1-Antitrypsin Deficiency: What Has It Ever Done for Us?. CHEST. 2013;144(6):1923-1930. Full Text

November 2013: A New Approach to Surveillance for Ventilator-Associated Events

Duration: 44 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Shelley S. Magill, MD, PhD; Craig M. Lilly, MD, FCCP

,

Articles Discussed:

  • Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Fridkin S et al. Developing a New, National Approach to Surveillance for Ventilator-Associated Events: Executive Summary. CHEST. 2013;144(5):1448-1452. Full Text
  • Lilly CM, Ellison III RT. Quality Measures for Critically Ill Patients: Where Does Ventilator-Associated Condition Fit In? CHEST. 2013;144(5):1429-1430. Full Text

October 2013: Should Fever Be Routinely Treated to Febrile Patients in Septic Shock?

Duration: 32 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Nicholas M. Mohr, MD; Anne M. Drewry, MD

,

Articles Discussed:

  • Mohr NM, Doerschug KC. Point: Should Antipyretic Therapy Be Given Routinely to Febrile Patients in Septic Shock? Yes. CHEST. 2013;144(4):1096-1098. Full Text
  • Drewry AM, Hotchkiss RS. Counterpoint: Should Antipyretic Therapy Be Given Routinely to Febrile Patients in Septic Shock? No. CHEST. 2013;144(4):1098-1101. Full Text
  • Mohr NM, Doerschug KC. Rebuttal From Drs Mohr and Doerschug. CHEST. 2013;144(4):1101-1102. Full Text
  • Drewry AM, Hotchkiss RS. Rebuttal From Drs Drewry and Hotchkiss. CHEST. 2013;144(4):1102-1103. Full Text

September 2013: Is EBUS-TBNA Always Preferable to Conventional TBNA?

Duration: 33 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Momen M. Wahidi, MD, MBA, FCCP; Robert Browning, MD, FCCP

,

Articles Discussed:

  • Wahidi MM, Yasufuku K. Point: Should Endobronchial Ultrasound Guide Every Transbronchial Needle Aspiration of Lymph Nodes? Yes. CHEST. 2013;144(3):732-734. Full Text
  • Huang JA, Browning R, Wang KP. Counterpoint: Should Endobronchial Ultrasound Guide Every Transbronchial Needle Aspiration of Lymph Nodes? No. CHEST. 2013;144(3):734-737. Full Text
  • Wahidi MM, Yasufuku K. Rebuttal From Drs Wahidi and Yasufuku. CHEST. 2013;144(3):737-738. Full Text
  • Huang JA, Browning R, Wang KP. Rebuttal From Dr Huang et al. CHEST. 2013;144(3):738-739. Full Text

September 2013: Commentary: Cognitive Services Are Undervalued in Current CPT Codes

Duration: 38 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participant: John D. Goodson, MD

,

Article Discussed:

  • Kumetz EA, Goodson JD. The Undervaluation of Evaluation and Management Professional Services: The Lasting Impact of Current Procedural Terminology Code Deficiencies on Physician Payment. CHEST. 2013;144(3):740-745. Full Text

August 2013: Assessing the Quality of Asthma Clinical Practice Guidelines

Duration: 33 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Pablo Alonso-Coello, PhD; Gordon Guyatt, MD, FCCP

,

Articles Discussed:

  • Acuna-Izcaray A, Sanchez-Angarita E, Plaza V, Rodrigo G, Montes de Oca M, Gich I, Bonfill X, Alonso-Coello A. Quality Assessment of Asthma Clinical Practice Guidelines: A Systematic Appraisal. CHEST. 2013;144(2):390-397. Full Text
  • Guyatt G, Vandvik PO. Creating Clinical Practice Guidelines: Problems and Solutions. CHEST. 2013;144(2):365-367. Full Text
  • Vandvik PO, Brandt L, Alonso-Coello P, Treweek S, Akl EA, Kristiansen A, Fog-Heen A, Agoritsas T, Montori VM, Guyatt G. Creating Clinical Practice Guidelines We Can Trust, Use, and Share: A New Era Is Imminent. CHEST. 2013:144(2):381-389. Full Text

July 2013: Surveillance Data for COPD in the United States, 1999-2011

Duration: 33 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Earl S. Ford, MD, MPH; David M. Mannino, MD, FCCP

,

Article Discussed:

  • Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD Surveillance--United States, 1999-2011. CHEST. 2013;144(1):284-305. Full Text

June 2013: Flock Worker's Lung Disease: A Natural History of an Occupational Lung Disease 

Duration: 44 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: M. Diane Lougheed, MD, FCCP; Kathleen Kreiss, MD

,

Articles Discussed:

  • Turcotte SE, Chee A, Walsh R, Grant FC, Liss GM, Boag A, Forkert L, Munt PW, Lougheed MD. Flock Worker's Lung Disease: Natural History of Cases and Exposed Workers in Kingston, Ontario. CHEST. 2013;143(5):1208-1213. Full Text
  • Kreiss K. Occupational Lung Disease: From Case Reports to Prevention. CHEST. 2013;143(6):1529-1531  Full Text

May 2013: Highlights of the ACCP Diagnosis and Management of Lung Cancer Guidelines, 3rd Ed

Duration: 33 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: W. Michael Alberts, MD, FCCP; Frank C. Detterbeck, MD, FCCP

,


Issue Discussed:

  • Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Issue

May 2013: Will New Trials on LABA in Asthma Safety Tell Us Anything New?

Duration: 26 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Samy Suissa, PhD

,


Article Discussed:

  • Suissa S, Ariel A. US Food and Drug Administration-Mandated Trials of Long-Acting β-Agonists Safety in Asthma: Will We Know the Answer. CHEST. 2013;143(5):1208-1213. Full Text

April 2013: How Many Supervised EBUS-TBNA Procedures Are Needed for Competency for Mediastinal Staging?

Duration: 34 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Erik Folch, MD; Colleen L. Channick, MD, FCCP

,


Articles Discussed:

  • Folch E, Majid A. Point: Are >50 Supervised Procedures Required to Develop Competency in Performing Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Mediastinal Staging? Yes. CHEST. 2013;143(4):888-891. Full Text
  • Kinsey CM, Channick CL. Counterpoint: Are >50 Supervised Procedures Required to Develop Competency in Performing Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Mediastinal Staging? No. CHEST. 2013;143(4):891-892. Full Text
  • Folch E, Majid A. Rebuttal From Drs Folch and Majid. CHEST. 2013;143(4):893-894. Full Text
  • Kinsey CM, Channick CL. Rebuttal From Drs Kinsey and Channick. CHEST. 2013;143(4):894-895. Full Text

March 2013: Acid-Suppressive Therapy for Patients With Chronic Cough

Duration: 36:50 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Peter J. Kahrilas, MD; Michael F. Vaezi, MD 

,


Articles Discussed:

  • Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of Chronic Cough to Acid-Suppressive Therapy in Patients With Gastroesophageal Reflux Disease. CHEST. 2013;143(3):605-612. Full Text
  • Vaezi MF. Chronic Cough and Gastroesophaegeal Reflux Disease. CHEST. 2013;143(3):587-589. Full Text

February 2013: Point/Counterpoint: Should Systemic Lytic Therapy Be Used for Submassive Pulmonary Embolism?

Duration: 40 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

 Participants: David Jimenez, MD, PhD; Susan Murin, MD, FCCP


Articles Discussed:

  • Jimenez, D. Point: Should Systemic Lytic Therapy Be Used for Submassive Pulmonary Embolism? Yes. CHEST. 2013;143(2):296-299. Full Text
  • Bilello KL, Murin S. Counterpoint: Should Systemic Lytic Therapy Be Used for Submassive Pulmonary Embolism? No. CHEST. 2013;143(2):299-302. Full Text
  • Jimenez D. Rebuttal From Dr Jimenez. CHEST. 2013;143(2):302-303. Full Text
  • Bilello KL, Murin S. Rebuttal From Drs Bilello and Murin. CHEST. 2013:143(2):303-304. Full Text

January 2013: The Cost of Critical Care Telemedicine: Can Its Value Be Determined?

Duration: 24:30 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

 Participants: Gaurav Kumar, MD; Don Eugene Detmer, MD; Karen S. Rheuban, MD


Articles Discussed:

  • Kumar G, Falk DM, Bonello RS, Kahn JM, Perencevich E, Cram P. The Costs of Critical Care Telemedicine Programs: a Systematic Review and Analysis. CHEST. 2013;143(1):19-29. Full Text
  • Detmer DE, Rheuban KS. A Difference Is a Difference If It Makes a Difference. CHEST. 2013;143(1):7-8. Full Text


December 2012: Anesthesiologist as Specialist of Choice for Managing the Difficult Airway  in the ICU. Yes or No?

Duration: 35 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: J. Matthias Walz, MD, FCCP; Kevin C. Doerschug, MD, FCCP


Articles Discussed:

  • Walz JM. Point: Should an Anesthesiologist Be the Specialist of Choice in Managing the Difficult Airway in the ICU? Yes. CHEST. 2012;142(6):1372-1375. Full Text
  • Doerschug KC. Counterpoint: Should an Anesthesiologist Be the Specialist of Choice in Managing the Difficult Airway in the ICU? Not Necessarily. CHEST. 2012;142(6):1375-1377. Full Text
  • Walz JM.Rebuttal From Dr Walz. CHEST. 2012;142(6):1377-1378. Full Text
  • Doerschug KC. Rebuttal from Dr. Doerschug. CHEST. 2012;142(6):1378-1379. Full Text

November 2012: Social Media for Physicians

Duration: 33 min

Moderator: Vicki Tedeschi, Managing Editor, CHEST

Participants: CHEST Social Media Editors Christopher L. Carroll, MD, FCCP; Deep Ramachandran, MBBS

 Special podcast highlighting how physicians can use social media to develop and monitor their reputations, spread the word about issues important to them, keep up with literature and scientific meetings, and develop a sense of community with others in their specialties.




October 2012: Issues in Diagnosing Heparin-Induced Thrombocytopenia in the ICU

Duration: 45 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Francois Stephan, MD, PhD; Theodore E. Warkentin, MD


Articles Discussed:

  • Trehel-Tursis V, Louvain-Quintard V, Zarrouki Y, Imbert A, Doubine S, Stephan F. Clinical and Biologic Features of Patients Suspected or Confirmed to Have Heparin-Induced Thrombocytopenia in a Cardiothoracic Surgical ICU. CHEST. 2012;142(4):837-844. Full Text
  • Warkentin TE. Heparin-Induced Thrombocytopenia in the ICU: A Transatlantic Perspective. CHEST. 2012;142(4):815-816. Full Text



September 2012: Efficacy of Lung Volume Reduction Coil Treatment in Patients with Severe Emphysema

Duration: 30:11 min

Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Dirk-Jan Slebos, MD, PhD; Jim Egan, MD


Articles Discussed:

  • Slebos DJ, Klooster K, Ernst A, Herth JF, Kerstjens HAM. Bronchoscopic Lung Volume Reduction Coil Treatment  of Patients With Severe Heterogenous Emphysema. CHEST. 2012;142(3):574-582. Full Text
  • Egan JJ. Emerging Bronchospoic Therapies for Stage IV Advanced Emphysema. CHEST. 2012;142(3):553-556. Full Text

August 2012: Benzodiazepines and the Risks for Mechanically Ventilated Patients
Duration: 36:30 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: E. Wesley Ely, MD, MPH, FCCP, Yoanna Skrobik, MD

Articles Discussed:

  • Ely EW, Dittus RS, Girard TD. Point: Should Benzodiazepines Be Avoided in Mechanically Ventilated Patients? Yes. CHEST. 2012;142(2):281-284. Full Text
  • Skrobik Y. Counterpoint: Should Benzodiazepines Be Avoided in Mechanically Ventilated Patients? No. CHEST. 2012;142(2):284-287. Full Text
  • Ely EW, Dittus RS, Girard TD. Rebuttal from Dr Ely et al. CHEST. 2012;142(2):287-289. Full Text
  • Skrobik Y. Rebuttal from Dr Skrobik. CHEST. 2012;142(2):289-290. Full Text

July 2012: Value of Thoracoscopic Talc Pleurodesis for Management of Malignant Pleural Effusion

Duration: 44:57 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST

Participants: Pyng Lee, MD, FCCP, Richard W. Light, MD, FCCP

Articles Discussed:

  • Lee P. Point: Should Thoracoscopic Talc Pleurodesis Be the First Choice Management for Malignant Effusion? Yes. CHEST. 2012;142(1):15-17. Full Text
  • Light RW. Counterpoint: Should Thoracoscopic Talc Pleurodesis Be the First Choice Management for Malignant Pleural Effusion. No. CHEST. 2012;142(1):17-19. Full Text
  • Lee P. Rebuttal from Dr Lee. CHEST. 2012;142(1):19. Full Text
  • Light RW. Rebuttal from Dr Light.  CHEST. 2012;142(1):20. Full Text

June 2012: Effects of Using Electronic Cigarettes
Duration: 40:14 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Constantine I. Vardavas, MD, MPH, PhD; Susan Murin, MD, FCCP; Mark V. Avdalovic, MD

Articles Discussed:

  • Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term Pulmonary Effects of Using an Electronic Cigarette: Impact on Respiratory Flow Resistance, Impedance, and Exhaled Nitric Oxide. CHEST. 2012;141(6):1400-1406. Full Text
  • Avdalovic MV, Murin S. Electronic Cigarettes: No Such Thing as a Free Lunch...or Puff. CHEST. 2012;141(6):1371-1372. Full Text

May 2012: Coagulopathy Repair and Central Venous Line Insertion
Duration: 36:58 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Rebecca M. Baron, MD; Samuel Z. Goldhaber, MD, FCCP



Articles Discussed:

  • Baron, RM. Point: Should Coagulopathy Be Repaired Prior to Central Venous Line Insertion? Yes: Why Take Chances? CHEST. 2012;141(5):1139-1142. Full Text
  • Goldhaber SZ. Counterpoint: Should Coagulopathy Be Repaired Prior to Central Venous Line Insertion? No. CHEST. 2012;141(5):1142-1144. Full Text
  • Baron, RM. Rebuttal From Dr. Baron. CHEST. 2012;141(5):1144-1145. Full Text
  • Goldhaber SZ. Rebuttal From Dr. Goldhaber. CHEST. 2012;141(5):1145-1146. Full Text


April 2012: Heart Disease and COPD Exacerbations
Duration: 35 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Anant R. C. Patel, MBBS; S. F. Paul Man, MD, FCCP


Articles Discussed:

  • Patel ARC, Donaldson GC, Mackay AJ, Wedzicha JA, Hurst JR. The Impact of Ischemic Heart Disease on Symptoms, Health Status, and Exacerbations in Patients with COPD. CHEST. 2012;141(4):851-857. Full Text
  • Man JP, Sin DD, Ignaszewski, Man SFP. The Complex Relationship Between Ischemic Heart Disease and COPD Exacerbations. CHEST. 2012;141(4):837-839. Full Text

March 2012: A New Web-Based Tool for Staging Lung Cancer
Duration: 16:31 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Anthony W. Kim, MD, FCCP; Frank C. Detterbeck, MD, FCCP

Article Discussed:

  • Kim, AW. Johnson KM, Detterbeck FC. The Lung Cancer Stage Page: There When You Need It--StagingLungCancer.org. CHEST. 2012;141(3):581-586 Full Text

February 2012 Part 1: Advancing Evidence-Based Medicine: ACCP Methodology
Duration: 48:58 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Gordon H. Guyatt, MD, FCCP; Ian T. Nathanson, MD, FCCP

Articles Discussed:

  • Guyatt GH, Norris SL, Schulman S, et al. Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Guidelines. CHEST. 2012;141(2)(Suppl):53S-70S Full Text
  • Metersky ML, Nathanson I. Introducing the Future of ACCP Clinical Practice Guidelines. CHEST. 2012;141(2):285-286. Full Text

February 2012 Part 2: New Drugs, New Recommendations: What Clinicians Must Know
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Mark A. Crowther, MD; David A. Garcia, MD

Articles Discussed:

  • Guyatt GH, Akl EA, Crowther MA, et al; for the American College of Chest Physicians Antithrombotic Therapy and the Prevention of Thrombosis Panel. Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Guidelines. CHEST. 2012;141(2)(Suppl):7S-47S Full Text
  • Highlights of the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

January 2012: The Role of Advance Directives in Aiding End-of-Life Decision Making
Duration: 52:23 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Robert S. Olick, JD, PhD; Mark D. Siegel, MD, FCCP

Articles Discussed:

  • Olick RS. Defining Features of Advance Directives in Law and Clinical Practice. CHEST. 2012;141(1):232-238 Full Text
  • Sauler M, Siegel, MD. The Past, Present, and Future of Advance Directives as a Guide to End-of-Life Decision Making. CHEST. 2012;141(1):9-10. Full Text

December 2011: Multicenter Study to Track Effect of Omission of Early Thromboprophylaxis on Mortality in Critically Ill Patients
Duration: 34:12 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Kwok M. Ho, PhD; Michael K. Gould, MD, FCCP

Articles Discussed:

  • Ho KM, Chavan S, Pilcher D. Omission of Early Thromboprophylaxis and Mortality in Critically Ill Patients: A Multicenter Registry Study. CHEST. 2011;140(6):1436-1446 Full Text
  • Gould MK, Jones JP. Thromboprophylaxis in the Real World: Strengths and Limitations of Comparative Effectiveness Research. CHEST. 2011;140(6):1401-1404. Full Text

November 2011: Benchmark Data to Assess Current Critical Care Practice in the United States
Duration: 42:53 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Craig M. Lilly, MD, FCCP; Neil A. Halpern, MD, FCCP

Articles Discussed:

  • Lilly CM, Zuckerman IH, Badawi O, Riker RR. Benchmark Data From More Than 240,000 Adults That Reflect the Current Practice of Critical Care in the United States. CHEST. 2011;140(5):1232-1242. Full Text
  • Halpern NA. From Telemedicine to a Critical Care Database: A New Resource for National Benchmarking. CHEST. 2011;140(5):1111-1113. Full Text

October 2011: Simulation Education To Improve Patient Safety
Duration: 50 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Rajesh Aggarwal, PhD; William F. Dunn, MD, FCCP

Articles Discussed:

  • Aggarwal R, Darzi A. Simulation to Enhance Patient Safety: Why Aren't We There Yet? CHEST. 2011;140(4):854-858. Full Text
  • Dunn WF, Murphy JG, Ziv A. Reengineering Health Care via Medical Simulation Tools: "Lions and Tigers and Bears, Oh My!" CHEST. 2011;140(4):840-842. Full Text

September 2011: Bronchial Thermoplasty for Patients With Severe Asthma Duration: 27:26 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Mario Castro, MD, FCCP; Gaetane Michaud, MD, FCCP

Articles Discussed:

  • Shifren A, Chen A, Castro M. Point: Efficacy of Bronchial Thermoplasty for Patients With Severe Asthma. Is There Sufficient Evidence? Yes. CHEST. 2011;140(3):573-575. Full Text
  • Michaud G, Ernst A. Counterpoint: Efficacy of Bronchial Thermoplasty for Patients With Severe Asthma. Is There Sufficient Evidence? Not Yet. CHEST. 2011;140(3):576-577. Full Text
  • Shifren A, Chen A, Castro M. Rebuttal from Dr Shifren et al. CHEST. 2011;140(3):577-578. Full Text
  • Michaud G, Ernst A. Rebuttal from Drs Michaud and Ernst. CHEST. 2011;140(3):578-579. Full Text

August 2011: FDA Regulatory Action on Unapproved Cough, Cold, and Allergy Medications
Duration: 34:38 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Charles E. Lee, MD; Richard S. Irwin, MD, FCCP

Articles Discussed:

  • Ostroff C, Lee CE, et al. Unapproved Prescription Cough, Cold, and Allergy Drug Products: Recent US Food and Drug Administration Regulatory Action on Unapproved Cough, Cold, and Allergy Medications CHEST. 2011;140(2):295-300. Full Text
  • Irwin RS, Smith BS. Managing Cough in the Aftermath of the Decision of the US Food and Drug Administration to Remove Unapproved Prescription Cough Medications From the Market CHEST. 2011;140(2):282-284. Full Text

July 2011: Low Tidal Volume Mechanical Ventilation Duration: 43:03 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Rolf D. Hubmayr, MD, FCCP; Luciano Gattinoni, MD


Articles Discussed:


  • Hubmayr RD. Point: Is Low Tidal Volume Mechanical Ventilation Preferred for All Patients on Ventilation? Yes. CHEST. 2011;140(1):9-11. Full Text
  • Gattinoni L. Counterpoint: Is Low Tidal Volume Mechanical Ventilation Preferred for All Patients on Ventilation? No. CHEST. 2011;140(1):11-13.Full Text
  • Hubmayr RD. Rebuttal from Dr Hubmayr CHEST. 2011;140(1):14-15. Full Text
  • Gattinoni L. Rebuttal from Dr Gattinoni CHEST. 2011;140(1):15. Full Text

June 2011: Pulmonary Rehabilitation in Practice Management Duration: 36:30 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Sam Birnbaum, BBA, CMPE; Brian W. Carlin, MD, FCCP

Article Discussed:

  • Birnbaum, S. Pulmonary rehabilitation: A classic tune with a new beat, but is anyone listening? CHEST 2011;139(6):1498-1502. Full Text

May 2011: Doppler Echocardiography in Pulmonary Hypertension
Duration: 34:50 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Evangelos D. Michelakis, MD; Jonathan D. Rich, MD

Articles Discussed:

  • Paterson I, Michelakis ED. The role of Doppler echocardiography in pulmonary artery hypertension: the importance of proving the obvious. CHEST. 2011;139(5):973-975. Full Text
  • Rich JD, Shah SJ, Swamy RS, Kamp A, Rich S. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. CHEST. 2011;139(5):988-993. Full Text

April 2011: Water-Pipe Tobacco Smoking Duration: 18:28 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Elie A. Akl, MD, PhD, MPH

Article Discussed:

  • Raad D, Gaddam S, Schunemann HJ et al. Effects of water-pipe smoking on lung function: a systematic review and meta-analysis. CHEST. 2011;139(4):764-774. Full Text

March 2011: Ventilator-Associated Tracheobronchitis Duration: 21:15 min
Moderator: D. Kyle Hogarth, MD, FCCP, Podcast Editor, CHEST
Participants: Richard G. Wunderink, MD, FCCP; Marin H. Kollef, MD, FCCP

Articles Discussed:

  • Wunderink RG. Ventilator-associated tracheobronchitis: public-reporting scam or important clinical infection. CHEST. 2011;139(3):485-488. Full Text
  • Dallas J, Skrupsky L, Abebe N, Boyle WA, III, Kollef MH. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. CHEST. 2011;139(3):513-518. Full Text
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543